搜尋結果
2023
Yang, S. C. ,
Ou, H. T. ,
Su, W. C. &
Wang, S. Y. ,
2023 4月 ,
於: Cancer medicine. 12 ,
7 ,
p. 8838-8850 13 p. 研究成果: Article › 同行評審
pembrolizumab
100%
Non-Small Cell Lung Carcinoma
84%
Immunotherapy
83%
Cost-Benefit Analysis
81%
Drug Therapy
55%
Su, H. Y. ,
Yang, C. Y. ,
Ou, H. T. ,
Chen, S. G. ,
Chen, J. C. ,
Ho, H. J. &
Kuo, S. ,
2023 1月 12 ,
於: JAMA network open. 6 ,
1 ,
p. E2250639 研究成果: Article › 同行評審
Health Care Sector
100%
Diabetic Foot
96%
Wound Healing
71%
Cost-Benefit Analysis
70%
Macrophages
56%
Su, P. F. ,
Zhong, J. ,
Liu, Y. C. ,
Lin, T. H. &
Ou, H. T. ,
2023 ,
於: Journal of Applied Statistics. 50 ,
10 ,
p. 2151-2170 20 p. 研究成果: Article › 同行評審
Cox Model
100%
Information Rates
99%
Efficient Estimation
93%
Incidence
65%
Subgroup
45%
Chung, W. P. ,
Yang, C. T. ,
Yang, S. R. ,
Su, C. Y. ,
Su, H. W. ,
Liu, S. Y. &
Ou, H. T. ,
2023 1月 24 ,
於: Frontiers in Oncology. 12 , 1022994.
研究成果: Article › 同行評審
Triple Negative Breast Neoplasms
100%
Neoadjuvant Therapy
95%
Platinum
87%
Survival
45%
Proportional Hazards Models
6%
Long-Acting Insulin
100%
Glucagon-Like Peptide-1 Receptor
86%
Chronic Renal Insufficiency
61%
Quality-Adjusted Life Years
58%
Cost-Benefit Analysis
57%
2022
Wang, W. M. ,
Ou, H. T. ,
Wen, M. J. ,
Su, P. F. ,
Yang, C. Y. ,
Kuo, T. H. ,
Wang, M. C. &
Lin, W. H. ,
2022 12月 ,
於: Scientific reports. 12 ,
1 , 4177.
研究成果: Article › 同行評審
Diabetic Retinopathy
100%
Type 1 Diabetes Mellitus
85%
Kidney
51%
Chronic Kidney Failure
38%
Propensity Score
9%
Yang, C. T. ,
Peng, Z. Y. ,
Chen, Y. C. ,
Ou, H. T. &
Kuo, S. ,
2022 3月 7 ,
於: Frontiers in Endocrinology. 13 , 836365.
研究成果: Article › 同行評審
Sodium-Glucose Transporter 2 Inhibitors
100%
Sodium-Glucose Transport Proteins
98%
Dipeptidyl-Peptidase IV Inhibitors
76%
Amputation
67%
Hypoglycemic Agents
65%
Lin, H. T. ,
Wu, M. H. ,
Tsai, L. C. ,
Chen, T. S. &
Ou, H. T. ,
2022 1月 14 ,
於: Frontiers in Endocrinology. 12 , 780392.
研究成果: Article › 同行評審
Letrozole
100%
Clomiphene
93%
Ovulation Induction
84%
Oocytes
67%
Fertilization
17%
Hsu, C. N. ,
Huang, K. ,
Lin, F. J. ,
Ou, H. T. ,
Huang, L. Y. ,
Kuo, H. C. ,
Wang, C. C. &
Toh, S. ,
2022 4月 4 ,
於: Frontiers in Pharmacology. 13 , 845949.
研究成果: Article › 同行評審
Electronic Health Records
100%
Hypoglycemic Agents
93%
Delivery of Health Care
59%
Comorbidity
45%
Databases
41%
Peng, Z. Y. ,
Yang, C. T. ,
Ou, H. T. &
Kuo, S. ,
2022 7月 ,
於: Diabetes, Obesity and Metabolism. 24 ,
7 ,
p. 1328-1337 10 p. 研究成果: Article › 同行評審
Sodium-Glucose Transport Proteins
100%
Dipeptidyl-Peptidase IV Inhibitors
93%
Quality-Adjusted Life Years
64%
Cost-Benefit Analysis
60%
Cardiovascular Diseases
51%
Lin, H. T. ,
Wu, M. H. ,
Wu, W. L. ,
Tsai, L. C. ,
Chen, Y. Y. ,
Hung, K. H. ,
Wu, P. H. ,
Chen, T. S. ,
Ou, H. T. &
Cheng, Y. S. ,
2022 5月 1 ,
於: Chinese Journal of Physiology. 65 ,
3 ,
p. 143-150 8 p. 研究成果: Article › 同行評審
Semen
100%
DNA Fragmentation
98%
Fertility
86%
Spermatozoa
85%
Chromatin
37%
Peng, Z. Y. ,
Yang, C. T. ,
Kuo, S. ,
Wu, C. H. ,
Lin, W. H. &
Ou, H. T. ,
2022 12月 15 ,
於: JAMA network open. 5 ,
12 ,
p. E2246928 研究成果: Article › 同行評審
Sodium-Glucose Transport Proteins
100%
Primary Prevention
72%
Secondary Prevention
68%
Survival Analysis
68%
Survival Rate
53%
Yang, C. Y. ,
Kuo, S. ,
Lai, E. C. C. &
Ou, H. T. ,
2022 12月 ,
於: Scientific reports. 12 ,
1 , 214.
研究成果: Article › 同行評審
Glucagon-Like Peptide-1 Receptor
100%
Pharmaceutical Preparations
53%
Propensity Score
27%
Reproducibility of Results
23%
Databases
15%
Chung, W. P. ,
Yang, C. T. ,
Chen, H. Y. ,
Su, C. Y. ,
Su, H. W. &
Ou, H. T. ,
2022 1月 ,
於: Journal of the Formosan Medical Association. 121 ,
1 ,
p. 319-328 10 p. 研究成果: Article › 同行評審
Triple Negative Breast Neoplasms
100%
Survival
45%
Drug Therapy
43%
Therapeutics
13%
taxane
11%
2021
Yang, C. T. ,
Li, K. Y. ,
Yang, C. Y. ,
Ou, H. T. &
Kuo, S. ,
2021 12月 ,
於: Scientific reports. 11 ,
1 , 4152.
研究成果: Article › 同行評審
Long-Acting Insulin
100%
Cohort Studies
45%
Insulin
45%
Blood Vessels
39%
Safety
38%
Liao, C. T. ,
Yang, C. T. ,
Chen, P. H. ,
Toh, H. S. ,
Kuo, S. ,
Chen, Z. C. ,
Ou, H. T. ,
Ko, N. Y. &
Wang, J. D. ,
2021 3月 1 ,
於: European Journal of Preventive Cardiology. 28 ,
3 ,
p. 326-334 9 p. 研究成果: Article › 同行評審
Cost of Illness
100%
Cardiovascular Diseases
61%
HIV
58%
Costs and Cost Analysis
35%
Population
33%
Yang, C. T. ,
Lin, W. H. ,
Li, L. J. ,
Ou, H. T. &
Kuo, S. ,
2021 8月 ,
於: Clinical Pharmacology and Therapeutics. 110 ,
2 ,
p. 464-472 9 p. 研究成果: Article › 同行評審
Dipeptidyl-Peptidase IV Inhibitors
100%
Chronic Renal Insufficiency
69%
Hypoglycemia
58%
Safety
44%
Kidney
40%
Huang, K. ,
Lin, F. J. ,
Ou, H. T. ,
Hsu, C. N. ,
Huang, L. Y. ,
Wang, C. C. &
Toh, S. ,
2021 1月 ,
於: Pharmacoepidemiology and drug safety. 30 ,
1 ,
p. 97-101 5 p. 研究成果: Article › 同行評審
Databases
57%
Safety
55%
Data Accuracy
33%
Pharmacovigilance
20%
Watchful Waiting
18%
Liao, C. T. ,
Yang, C. T. ,
Toh, H. S. ,
Chang, W. T. ,
Chang, H. Y. ,
Kuo, F. H. ,
Lee, M. C. ,
Hua, Y. M. ,
Tang, H. J. ,
Strong, C. &
Ou, H. T. ,
2021 12月 ,
於: Cardiovascular Diabetology. 20 ,
1 , 204.
研究成果: Article › 同行評審
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
100%
Cost-Benefit Analysis
55%
Delivery of Health Care
39%
Costs and Cost Analysis
29%
Quality-Adjusted Life Years
17%
Yang, C. Y. ,
Chen, Y. R. ,
Ou, H. T. &
Kuo, S. ,
2021 12月 ,
於: Cardiovascular Diabetology. 20 ,
1 , 21.
研究成果: Article › 同行評審
Glucagon-Like Peptide-1 Receptor
100%
Cost-Benefit Analysis
66%
Systematic Reviews
57%
Insulin
52%
Costs and Cost Analysis
32%
Anderson, S. J. ,
Hsu, C. Y. ,
Ou, H. T. ,
Ko, N. Y. ,
Yang, C. T. &
Lopes, S. ,
2021 5月 ,
於: Value in Health Regional Issues. 24 ,
p. 216-223 8 p. 研究成果: Article › 同行評審
rilpivirine drug combination dolutegravir
100%
Rilpivirine
66%
dolutegravir
64%
Cost-effectiveness
57%
Infection
47%
Lin, W. H. ,
Yang, C. Y. ,
Kuo, S. ,
Kuo, T. H. ,
Roan, J. N. ,
Li, C. Y. ,
Wang, M. C. &
Ou, H. T. ,
2021 2月 ,
於: Diabetes Research and Clinical Practice. 172 , 108489.
研究成果: Article › 同行評審
Acarbose
100%
Chronic Kidney Failure
61%
Longitudinal Studies
58%
Safety
40%
Liver
36%
Yang, C. Y. ,
Lin, W. A. ,
Su, P. F. ,
Li, L. J. ,
Yang, C. T. ,
Ou, H. T. &
Kuo, S. ,
2021 3月 ,
於: Clinical Pharmacology and Therapeutics. 109 ,
3 ,
p. 772-781 10 p. 研究成果: Article › 同行評審
Dipeptidyl-Peptidase IV Inhibitors
100%
Cardiovascular Diseases
54%
Confidence Intervals
45%
Stroke
38%
Therapeutics
12%
Chen, H. Y. ,
Yang, C. Y. ,
Hsieh, C. Y. ,
Yeh, C. Y. ,
Chen, C. C. ,
Chen, Y. C. ,
Lai, C. C. ,
Harris, R. C. ,
Ou, H. T. ,
Ko, N. Y. &
Ko, W. C. ,
2021 9月 ,
於: PLoS neglected tropical diseases. 15 ,
9 , e0009703.
研究成果: Article › 同行評審
Healthcare
53%
Delivery of Health Care
42%
mortality
38%
vaccination
38%
epilepsy
28%
Wu, M. H. ,
Su, P. F. ,
Chu, W. Y. ,
Lin, C. W. ,
Huey, N. G. ,
Lin, C. Y. &
Ou, H. T. ,
2021 ,
於: Journal of Psychosomatic Obstetrics and Gynaecology. 42 ,
1 ,
p. 57-66 10 p. 研究成果: Article › 同行評審
Fertilization
100%
Endometriosis
97%
Pregnancy Outcome
93%
pregnancy
79%
quality of life
74%
Wu, M. H. ,
Chong, K. S. ,
Huey, N. G. ,
Ou, H. T. &
Lin, C. Y. ,
2021 3月 ,
於: Journal of the Formosan Medical Association. 120 ,
3 ,
p. 939-946 8 p. 研究成果: Article › 同行評審
Pregnancy Outcome
100%
Fertilization in Vitro
64%
Quality of Life
64%
Live Birth
62%
Pregnancy
48%
Johnson, B. ,
Lai, E. C. C. ,
Ou, H. T. ,
Li, H. &
Stollenwerk, B. ,
2021 12月 ,
於: Archives of Osteoporosis. 16 ,
1 , 155.
研究成果: Article › 同行評審
Denosumab
100%
Postmenopausal Osteoporosis
87%
Cost-Benefit Analysis
61%
Quality-Adjusted Life Years
39%
Fracture Fixation
24%
Lin, F. J. ,
Wang, C. C. ,
Hsu, C. N. ,
Yang, C. Y. ,
Wang, C. Y. &
Ou, H. T. ,
2021 12月 ,
於: Cardiovascular Diabetology. 20 ,
1 , 203.
研究成果: Article › 同行評審
Sodium-Glucose Transporter 2 Inhibitors
100%
Glomerular Filtration Rate
65%
Sodium-Glucose Transport Proteins
40%
Kidney
37%
Glucose
25%
Kuo, S. ,
Yang, C. T. ,
Chen, H. Y. &
Ou, H. T. ,
2021 9月 ,
於: Journal of Diabetes Investigation. 12 ,
9 ,
p. 1749-1758 10 p. 研究成果: Article › 同行評審
Databases
100%
Health
80%
Connective Tissue Diseases
80%
Quality of Life
64%
Stroke
45%
2020
Su, P. F. ,
Sie, F. C. ,
Yang, C. T. ,
Mau, Y. L. ,
Kuo, S. &
Ou, H. T. ,
2020 12月 1 ,
於: Environmental Health: A Global Access Science Source. 19 ,
1 , 110.
研究成果: Article › 同行評審
Air Pollution
100%
Spatial Analysis
98%
cardiovascular disease
96%
chronic illness
75%
Survival Analysis
74%
Wu, M. H. ,
Lin, C. W. ,
Su, P. F. ,
Lai, E. C. C. ,
Sie, F. C. ,
Mau, Y. L. ,
Huey, N. G. &
Ou, H. T. ,
2020 3月 1 ,
於: Reproductive Sciences. 27 ,
3 ,
p. 853-859 7 p. 研究成果: Article › 同行評審
atosiban
100%
Embryo Transfer
68%
Fertilization in Vitro
63%
Pregnancy Outcome
59%
Longitudinal Studies
49%
Yang, C. T. ,
Yang, C. Y. ,
Ou, H. T. &
Kuo, S. ,
2020 6月 13 ,
於: Cardiovascular Diabetology. 19 ,
1 , 83.
研究成果: Article › 同行評審
Glucagon-Like Peptide-1 Receptor
100%
Cohort Studies
52%
Glucose
48%
Dipeptidyl-Peptidase IV Inhibitors
45%
Safety
45%
Chang, K. C. ,
Shao, S. C. ,
Kuo, S. ,
Yang, C. Y. ,
Chen, H. Y. ,
Chan, Y. Y. &
Ou, H. T. ,
2020 10月 9 ,
於: Cardiovascular Diabetology. 19 ,
1 , 172.
研究成果: Article › 同行評審
dulaglutide
100%
Liraglutide
81%
Meta-Analysis
43%
Cohort Studies
39%
Blood Pressure
18%
Yang, C. Y. ,
Su, P. F. ,
Hung, J. Y. ,
Ou, H. T. &
Kuo, S. ,
2020 7月 6 ,
於: Cardiovascular Diabetology. 19 ,
1 , 105.
研究成果: Article › 同行評審
Risk Adjustment
19%
Semantic Web
18%
Proportional Hazards Models
13%
University Hospitals
11%
Comorbidity
11%
Lee, T. Y. ,
Kuo, S. ,
Yang, C. Y. &
Ou, H. T. ,
2020 5月 1 ,
於: British Journal of Clinical Pharmacology. 86 ,
5 ,
p. 852-860 9 p. 研究成果: Article › 同行評審
insulin, long-acting, human
100%
Long-Acting Insulin
79%
Hypoglycemia
51%
Type 1 Diabetes Mellitus
47%
Cost-Benefit Analysis
45%
Lee, T. Y. ,
Chen, H. Y. ,
Chen, T. Y. ,
Li, S. S. ,
Fang, W. T. ,
Wen, Y. C. ,
Lo, Y. W. &
Ou, H. T. ,
2020 9月 1 ,
於: European Journal of Health Economics. 21 ,
7 ,
p. 1105-1116 12 p. 研究成果: Article › 同行評審
Inotuzumab Ozogamicin
100%
utility analysis
84%
Cost-utility Analysis
83%
Health Care System
54%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
53%
Yang, C. T. ,
Toh, H. S. ,
Liao, C. T. ,
Kuo, S. ,
Ou, H. T. &
Ko, N. Y. ,
2020 5月 1 ,
於: AIDS. 34 ,
6 ,
p. 903-911 9 p. 研究成果: Article › 同行評審
Cost of Illness
100%
HIV
58%
Population
33%
Cardiovascular Diseases
15%
Therapeutics
13%
Chen, H. Y. ,
Kuo, S. ,
Su, P. F. ,
Wu, J. S. &
Ou, H. T. ,
2020 8月 ,
於: Diabetes Care. 43 ,
8 ,
p. 1732-1740 9 p. 研究成果: Article › 同行評審
Health Care Costs
100%
Costs and Cost Analysis
69%
Diabetes Complications
48%
Population
43%
Economics
37%
Chen, H. ,
Kuo, S. ,
Su, P. ,
Wu, J. &
Ou, H. ,
2020 8月 1 ,
於: Diabetes Care. 43 ,
8 ,
p. 1732-1740 研究成果: Article › 同行評審
Wu, M. ,
Su, P. ,
Chu, W. ,
Lin, C. ,
Huey, N. G. ,
Lin, C. &
Ou, H. ,
2020 4月 , (Accepted/In press)
於: Journal of Psychosomatic Obstetrics and Gynaecology. p. 1-10 研究成果: Article › 同行評審
Wu, M. H. ,
Su, P. F. ,
Chu, W. Y. ,
Huey, N. G. ,
Lin, C. W. ,
Ou, H. T. &
Lin, C. Y. ,
2020 1月 ,
於: Journal of the Formosan Medical Association. 119 ,
1P3 ,
p. 471-479 9 p. 研究成果: Article › 同行評審
Fertilization in Vitro
100%
Pregnancy Outcome
93%
Longitudinal Studies
77%
Cohort Studies
63%
Quality of Life
59%
Toh, H. S. ,
Yang, C. T. ,
Yang, K. L. ,
Ku, H. C. ,
Liao, C. T. ,
Kuo, S. ,
Tang, H. J. ,
Ko, W. C. ,
Ou, H. T. &
Ko, N. Y. ,
2020 2月 ,
於: International Journal of Infectious Diseases. 91 ,
p. 44-49 6 p. 研究成果: Article › 同行評審
Economics
92%
Costs and Cost Analysis
74%
Medication Adherence
44%
Cytomegalovirus
39%
Varicella Zoster Virus Infection
28%
2019
Chang, H. H. ,
Hsueh, Y. S. ,
Cheng, Y. W. ,
Ou, H. T. &
Wu, M. H. ,
2019 4月 1 ,
於: International journal of molecular sciences. 20 ,
7 , 1720.
研究成果: Article › 同行評審
ovaries
100%
polymorphism
87%
Polycystic Ovary Syndrome
75%
Metformin
73%
Metabolic
55%
Kuo, S. ,
Yang, C. T. ,
Wu, J. S. &
Ou, H. T. ,
2019 2月 ,
於: Diabetes, Obesity and Metabolism. 21 ,
2 ,
p. 312-320 9 p. 研究成果: Article › 同行評審
Propensity Score
100%
Hypoglycemic Agents
88%
Cohort Studies
63%
Insulin
63%
Confidence Intervals
55%
Ou, H. T. ,
Chung, W. P. ,
Su, P. F. ,
Lin, T. H. ,
Lin, J. Y. ,
Wen, Y. C. &
Fang, W. T. ,
2019 7月 ,
於: European Journal of Cancer Care. 28 ,
4 , e13069.
研究成果: Article › 同行評審
Cancer Survivors
100%
Quality of Life
58%
Drug Therapy
33%
Neoplasms
29%
Linear Models
26%
Taiwan
38%
Biased Estimation
37%
Hypoglycemia
36%
Diabetes
34%
Period of time
30%
2018
Ou, H. T. ,
Lee, T. Y. ,
Du, Y. F. &
Li, C. Y. ,
2018 2月 ,
於: British Journal of Clinical Pharmacology. 84 ,
2 ,
p. 379-391 13 p. 研究成果: Article › 同行評審
insulin, long-acting, human
100%
Long-Acting Insulin
95%
Insulins
91%
Diabetes Complications
64%
Type 1 Diabetes Mellitus
56%
Hou, W. H. ,
Chang, K. C. ,
Li, C. Y. &
Ou, H. T. ,
2018 9月 ,
於: British Journal of Clinical Pharmacology. 84 ,
9 ,
p. 2029-2039 11 p. 研究成果: Article › 同行評審
Dipeptidyl-Peptidase IV Inhibitors
100%
Cohort Studies
51%
Population
29%
Protease Inhibitors
26%
Upper Extremity
23%
Wu, M. H. ,
Su, P. F. ,
Chen, K. Y. ,
Tie, T. H. ,
Ke, H. C. ,
Chen, H. ,
Su, Y. C. ,
Su, Y. C. &
Ou, H. T. ,
2018 3月 ,
於: PloS one. 13 ,
3 , e0193899.
研究成果: Article › 同行評審
Fertilization in Vitro
100%
Heart Rate
67%
Pregnancy
56%
Embryo Transfer
33%
Live Birth
24%